Cargando…
Stapled ACE2 peptidomimetics designed to target the SARS‐CoV‐2 spike protein do not prevent virus internalization
COVID‐19 is caused by a novel coronavirus called severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2). Virus cell entry is mediated through a protein‐protein interaction (PPI) between the SARS‐CoV‐2 spike protein and angiotensin‐converting enzyme 2 (ACE2). A series of stapled peptide ACE2 pe...
Autores principales: | Morgan, Danielle C., Morris, Caroline, Mahindra, Amit, Blair, Connor M., Tejeda, Gonzalo, Herbert, Imogen, Turnbull, Matthew L., Lieber, Gauthier, Willett, Brian J., Logan, Nicola, Smith, Brian, Tobin, Andrew B., Bhella, David, Baillie, George, Jamieson, Andrew G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7883042/ https://www.ncbi.nlm.nih.gov/pubmed/33615115 http://dx.doi.org/10.1002/pep2.24217 |
Ejemplares similares
-
Peptides derived from the SARS-CoV-2 receptor binding motif bind to ACE2 but do not block ACE2-mediated host cell entry or pro-inflammatory cytokine induction
por: Mahindra, Amit, et al.
Publicado: (2021) -
Novel Polymyxin-Inspired Peptidomimetics Targeting the SARS-CoV-2 Spike:hACE2 Interface
por: Bugatti, Kelly, et al.
Publicado: (2023) -
Synthesis of HDAC Substrate Peptidomimetic Inhibitors
Using Fmoc Amino Acids Incorporating Zinc-Binding Groups
por: Mahindra, Amit, et al.
Publicado: (2019) -
Identification of a short ACE2-derived stapled peptide targeting the SARS-CoV-2 spike protein
por: Calugi, Lorenzo, et al.
Publicado: (2023) -
Peptidomimetic Small-Molecule
Inhibitors of 3CLPro
Activity and Spike–ACE2 Interaction: Toward Dual-Action Molecules
against Coronavirus Infections
por: Tedesco, Filomena, et al.
Publicado: (2022)